Dr Kara Vine-Perrow. Photo by Mark Newsham.

IHMRI researcher Dr Kara Vine-Perrow from UOW’s School of Biological Sciences. Photo by Mark Newsham.

New Dr Margaret Gardiner Scholarship for Medical Research

Dr Kara Vine-Perrow has been awarded a new scholarship for cancer research in honour of Dr Margaret Gardiner at the 2018 International Women’s Day Luncheon in Wollongong on 2 March 2018.

Dr Margaret Gardiner was a renowned Wollongong GP and public advocate for breast cancer awareness. She was diagnosed with breast cancer in 2000 and became an active fundraiser to find a cure.

Dr Vine-Perrow and colleagues are investigating the role non-cancerous cells play in the progression of tumours and the response to therapy in breast and other cancers.

“The key toward curing diseases like cancer lies in fostering new collaborations between leading researchers around the world, and sharing our understanding of the disease as rapidly as possible,” said Dr Vine-Perrow.

Dr Vine-Perrow will put the $2000 Dr Margaret Gardiner Scholarship for Medical Research towards travel costs to attend the European Association for Cancer Research Conference in Portugal in June 2018.

Dr Kara Vine-Perrow with TV presenter Jessica Rowe, who was the guest speaker at the International Women's Day Luncheon.

Dr Kara Vine-Perrow with TV presenter Jessica Rowe, who was the guest speaker at the International Women’s Day Luncheon.

Last year, along with lead researchers at the University of Wollongong (UOW) and the Garvan Institute of Medical Research, Dr Vine-Perrow and colleagues published a seminal paper on the role that the enzyme inhibitor, Plasminogen activator inhibitor-2 (PAI-2), plays in pancreatic cancer. Their research showed that elevated levels, particularly in the microenvironment, is associated with reduced metastasis and prolonged survival in pancreatic cancer patients.

Dr Vine-Perrow and her team are now further investigating this as a potential therapeutic target in pancreatic and breast cancer. They have developed nanoparticle-based therapies to target multiple cell types within the tumour to improve patient response to therapy.

Dr Vine-Perrow received her PhD in cancer biology from UOW in 2007, and is now group leader of the Targeted Cancer Therapeutics Research Laboratory at IHMRI.

Her current research is centred on the development of implantable and targeted drug delivery systems for the treatment of pancreatic and breast cancer.

Dr Vine-Perrow has a strong connection with the Illawarra Cancer Carers and has a long-standing commitment to the involvement of cancer survivors in the design and conduct of her medical research.

Louise Negline, Professor David J. Adams, Dr Kara Vine-Perrow, Kara Lamond and Jean Marshall.

IHMRI Communications Coordinator, Louise Negline; IHMRI Executive Director and CEO, Professor David J. Adams; Dr Kara Vine Perrow, IHMRI Chief Operating Officer, Kara Lamond; and IHMRI Research Development Coordinator, Jean Marshall.

Media coverage

Illawarra Mercury

2 March 2018: Illawarra International Women’s Day scholarship winners

WIN News Illawarra

Nine News Illawarra

Media contact

Louise Negline, Communications Coordinator
E: lnegline@uow.edu.au 
T: +61 2 4221 4702 
M: +61 417 044 867

You may also like

Dr Daniel Brungs, Professor Marie Ranson, Clinical Professor Morteza Aghmesheh and Dr Martin Carolan.
Wollongong’s Biobank helping IHMRI cancer researchers
Greg Barclay and Professor Frank Deane.
Supporting and encouraging collaborative research
Dr Martin Engel. Photo by Grabowski.
Recognising and supporting emerging research talent